- Is it possible to receive only the antibody sequence data?
We can accommodate your needs, from supplying only VHH amino acid sequences and DNA sequences to supplying purified proteins.
- Do you have experience with requests from overseas or collaborative research with overseas companies?
Yes, we do. We can also assist you in English, so please contact us through the inquiry form.
- What is the estimated time and cost involved in obtaining candidate VHH antibodies?
Candidate VHH antibodies can be identified within 30 business days from the start of screening. Please contact us for pricing, as it depends on the difficulty of the target, screening conditions, and desired deliverables.
- Is it possible to purchase the cnvK linker as a reagent?
We offer this product as a research reagent to academics only, on a paid basis (however, there are restrictions on its use).
For commercial use, a separate license agreement is required. Please contact us for details. - To what extent can affinity be obtained?
While it varies depending on the target, we have a track record of obtaining high-affinity VHH antibodies in the pM order. We will propose screening and optimization according to your required affinity.
- Can I consult with you about antigen design?
Yes. We will propose the optimal screening strategy, including antigen preparation methods, expression systems, and whether or not tags are used.
- Is it possible to obtain antibodies that do not bind to specific molecules?
Yes, it is possible. By combining negative screening using closely related molecules or unwanted binding partners, we aim to obtain antibodies with high selectivity.
- Is it possible to obtain antibodies targeting a specific epitope?
Yes, it is possible. We can help you obtain antibodies that meet your needs through negative screening using competing molecules and screening designs that focus on specific sites.
- Is it possible to obtain antibodies against difficult-to-treat membrane proteins?
Yes, it is possible. We also offer screening using expression cells and membrane fractions, and we can discuss even difficult-to-purify targets such as GPCRs and ion channels.
- Is screening possible with small sample sizes (antigens)?
Yes, it is possible. Depending on the size of the antigen, we can use antigens starting from several tens of micrograms for screening.